Does GEMFIBROZIL Cause Rhabdomyolysis? 63 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Rhabdomyolysis have been filed in association with GEMFIBROZIL (Gemfibrozil). This represents 5.8% of all adverse event reports for GEMFIBROZIL.
63
Reports of Rhabdomyolysis with GEMFIBROZIL
5.8%
of all GEMFIBROZIL reports
4
Deaths
50
Hospitalizations
How Dangerous Is Rhabdomyolysis From GEMFIBROZIL?
Of the 63 reports, 4 (6.3%) resulted in death, 50 (79.4%) required hospitalization, and 15 (23.8%) were considered life-threatening.
Is Rhabdomyolysis Listed in the Official Label?
Yes, Rhabdomyolysis is listed as a known adverse reaction in the official FDA drug label for GEMFIBROZIL.
What Other Side Effects Does GEMFIBROZIL Cause?
Drug hypersensitivity (242)
Drug ineffective (77)
Fatigue (60)
Drug interaction (59)
Myalgia (58)
Nausea (54)
Acute kidney injury (52)
Diarrhoea (43)
Rash (41)
Completed suicide (40)
What Other Drugs Cause Rhabdomyolysis?
ATORVASTATIN (3,286)
ROSUVASTATIN (2,173)
SIMVASTATIN (1,616)
LEVETIRACETAM (1,183)
QUETIAPINE (971)
OLANZAPINE (647)
ACETAMINOPHEN (630)
METFORMIN (603)
RISPERIDONE (527)
ARIPIPRAZOLE (516)
Which GEMFIBROZIL Alternatives Have Lower Rhabdomyolysis Risk?
GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN
GEMFIBROZIL vs GEMZAR
GEMFIBROZIL vs GENTAMICIN
GEMFIBROZIL vs GEODON
GEMFIBROZIL vs GILENYA